Virtu Financial LLC Atara Biotherapeutics, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$0.23 - $1.74 $1,875 - $14,189	8,155 Added 78.97%	18,482 $9,000
Q3 2023 Nov 14, 2023	SELL	$1.41 - $2.31 $2,711 - $4,442	-1,923 Reduced 15.7%	10,327 $15,000
Q2 2023 Jul 27, 2023	BUY	$1.5 - $3.04 $18,375 - $37,240	12,250 New	12,250 $20,000
Q3 2021 Nov 12, 2021	SELL	$11.99 - $17.9 $152,033 - $226,971	-12,680 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$12.89 - $16.58 $163,445 - $210,234	12,680 New	12,680 $197,000
Q2 2018 Jul 30, 2018	SELL	$35.15 - $51.45 $262,394 - $384,074	-7,465 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$35.15 - $51.45 $262,394 - $384,074	7,465 New	7,465 $274,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.13B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.